A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses

Asadullah, 2003, Interleukin-10 therapy-review of a new approach, Pharmacol. Rev., 55, 241, 10.1124/pr.55.2.4 Berg, 1995, Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses, J. Exp. Med., 182, 99, 10.1084/jem.182.1.99 Bouaziz, 2007, Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice, Proc. Natl. Acad. Sci. USA, 104, 20882, 10.1073/pnas.0709205105 Brummel, 2005, Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides, J. Immunol., 174, 2429, 10.4049/jimmunol.174.4.2429 Bursch, 2007, Identification of a novel population of Langerin+ dendritic cells, J. Exp. Med., 204, 3147, 10.1084/jem.20071966 Constant, 1995, B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo, J. Immunol., 155, 3734, 10.4049/jimmunol.155.8.3734 Dass, 2007, Development of psoriasis after B cell depletion with rituximab, Arthritis Rheum., 56, 2715, 10.1002/art.22811 DiLillo, 2008, Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice, J. Immunol., 180, 361, 10.4049/jimmunol.180.1.361 Duan, 2007, Lupus resistance is associated with marginal zone abnormalities in an NZM murine model, Lab. Invest., 87, 14, 10.1038/labinvest.3700497 Edwards, 2006, B-cell targeting in rheumatoid arthritis and other autoimmune diseases, Nat. Rev. Immunol., 6, 394, 10.1038/nri1838 Evans, 2007, Novel suppressive function of transitional 2 B cells in experimental arthritis, J. Immunol., 178, 7868, 10.4049/jimmunol.178.12.7868 Ferguson, 1994, Regulation of contact hypersensitivity by interleukin 10, J. Exp. Med., 179, 1597, 10.1084/jem.179.5.1597 Fillatreau, 2002, B cells regulate autoimmunity by provision of IL-10, Nat. Immunol., 3, 944, 10.1038/ni833 Goetz, 2007, Exacerbation of ulcerative colitis after rituximab salvage therapy, Inflamm. Bowel Dis., 13, 1365, 10.1002/ibd.20215 Haas, 2005, B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae, Immunity, 23, 7, 10.1016/j.immuni.2005.04.011 Hamaguchi, 2005, The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice, J. Immunol., 174, 4389, 10.4049/jimmunol.174.7.4389 Harris, 2000, Reciprocal regulation of polarized cytokine production by effector B and T cells, Nat. Immunol., 1, 475, 10.1038/82717 Hasegawa, 2006, B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis, Am. J. Pathol., 169, 954, 10.2353/ajpath.2006.060205 Hauser, 2008, B-cell depletion with rituximab in relapsing-remitting multiple sclerosis, N. Engl. J. Med., 358, 676, 10.1056/NEJMoa0706383 Inaoki, 1997, CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes, J. Exp. Med., 186, 1923, 10.1084/jem.186.11.1923 Itakura, 2005, An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity, J. Immunol., 175, 7170, 10.4049/jimmunol.175.11.7170 Kripke, 1990, Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization, J. Immunol., 145, 2833, 10.4049/jimmunol.145.9.2833 Kuhn, 1993, Interleukin-10-deficient mice develop chronic enterocolitis, Cell, 75, 263, 10.1016/0092-8674(93)80068-P Linton, 2003, Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo, J. Exp. Med., 197, 875, 10.1084/jem.20021290 Mann, 2007, B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis, J. Immunol., 178, 3447, 10.4049/jimmunol.178.6.3447 Martin, 2001, Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens, Immunity, 14, 617, 10.1016/S1074-7613(01)00129-7 Matsushita, 2006, Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response, Am. J. Pathol., 168, 812, 10.2353/ajpath.2006.050923 Mauri, 2003, Prevention of arthritis by interleukin 10-producing B cells, J. Exp. Med., 197, 489, 10.1084/jem.20021293 McGeachy, 2005, Natural recovery and protection from autoimmune encephalomyelitis: Contribution of CD4+CD25+ regulatory cells within the central nervous system, J. Immunol., 175, 3025, 10.4049/jimmunol.175.5.3025 Mizoguchi, 2006, A case for regulatory B cells, J. Immunol., 176, 705, 10.4049/jimmunol.176.2.705 Mizoguchi, 2002, Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation, Immunity, 16, 219, 10.1016/S1074-7613(02)00274-1 Sato, 1996, CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity, J. Immunol., 157, 4371, 10.4049/jimmunol.157.10.4371 Sato, 1997, CD19 expression levels regulate B lymphocyte development: Human CD19 restores normal function in mice lacking endogenous CD19, J. Immunol., 158, 4662, 10.4049/jimmunol.158.10.4662 Sato, 1995, The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation, Proc. Natl. Acad. Sci. USA, 92, 11558, 10.1073/pnas.92.25.11558 Schwarz, 1994, In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions, J. Invest. Dermatol., 103, 211, 10.1111/1523-1747.ep12393073 Spencer, 1997, IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5- B cells: Possible involvement in age-associated cytokine dysregulation, Int. Immunol., 9, 745, 10.1093/intimm/9.5.745 Tedder, 1998, Response-regulators of B lymphocyte signaling thresholds provide a context for antigen receptor signal transduction, Semin. Immunol., 10, 259, 10.1006/smim.1998.0118 Tedder, 1995, L-selectin deficient mice have impaired leukocyte recruitment into inflammatory sites, J. Exp. Med., 181, 2259, 10.1084/jem.181.6.2259 Uchida, 2004, The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy, J. Exp. Med., 199, 1659, 10.1084/jem.20040119 Uchida, 2004, Mouse CD20 expression and function, Int. Immunol., 16, 119, 10.1093/intimm/dxh009 Venturi, 2003, Leukocyte migration is regulated by L-selectin endoproteolytic release, Immunity, 19, 713, 10.1016/S1074-7613(03)00295-4 Wang, 2000, CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity, J. Immunol., 165, 6783, 10.4049/jimmunol.165.12.6783 Watanabe, 2007, CD19 expression in B cells is important for suppression of contact hypersensitivity, Am. J. Pathol., 171, 560, 10.2353/ajpath.2007.061279 Xiu, 2008, B lymphocytes depletion by CD20 monoclonal antibody prevents diabetes in NOD mice despite isotype-specific differences in FcγR effector functions, J. Immunol., 180, 2863, 10.4049/jimmunol.180.5.2863 Yanaba, 2007, B cell depletion delays collagen-induced arthritis in mice: Arthritis induction requires synergy between humoral and cell-mediated immunity, J. Immunol., 179, 1369, 10.4049/jimmunol.179.2.1369 Yazawa, 2005, Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease, Proc. Natl. Acad. Sci. USA, 102, 15178, 10.1073/pnas.0505539102